Accretive Health updates its ongoing financial restatement timeline to which investors responded with two emphatic thumbs down.
News & Analysis: Accretive Health
Sean F. Orr is a poach from the CFO's post at Maxum Petroleum.
The Fool looks at 3 horrendous health-care stocks from the past week.
Did Accretive Health deserve today's selloff?
With a 48.1% loss this year, Accretive Health lands at No. 8 on our countdown of the very worst healthcare stocks of 2012.
Just the facts, Fool.
Is this meaningful or just another movement?
Accretive Health gave investors a wild ride in 2012, but it's time to exit.
Open and televised shareholder meetings would be a step in the right direction for shareholders.